Treace Medical Concepts, Inc.
TMCI
$1.24
-$0.07-5.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.52M | 50.21M | 47.39M | 52.57M | 68.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.52M | 50.21M | 47.39M | 52.57M | 68.71M |
| Cost of Revenue | 12.12M | 10.51M | 9.64M | 10.68M | 13.23M |
| Gross Profit | 50.40M | 39.71M | 37.75M | 41.89M | 55.48M |
| SG&A Expenses | 51.78M | 49.70M | 49.23M | 51.91M | 50.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.44M | 64.89M | 64.36M | 68.15M | 68.91M |
| Operating Income | -5.92M | -14.68M | -16.97M | -15.58M | -204.00K |
| Income Before Tax | -9.39M | -16.29M | -17.40M | -15.92M | -501.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.39M | -16.29M | -17.40M | -15.92M | -501.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.39M | -16.29M | -17.40M | -15.92M | -501.00K |
| EBIT | -5.92M | -14.68M | -16.97M | -15.58M | -204.00K |
| EBITDA | -4.11M | -11.90M | -14.40M | -13.12M | 1.03M |
| EPS Basic | -0.15 | -0.26 | -0.28 | -0.25 | -0.01 |
| Normalized Basic EPS | -0.07 | -0.15 | -0.17 | -0.16 | -0.01 |
| EPS Diluted | -0.15 | -0.26 | -0.28 | -0.25 | -0.01 |
| Normalized Diluted EPS | -0.07 | -0.15 | -0.17 | -0.16 | -0.01 |
| Average Basic Shares Outstanding | 63.86M | 63.52M | 63.01M | 62.66M | 62.34M |
| Average Diluted Shares Outstanding | 63.86M | 63.52M | 63.01M | 62.66M | 62.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |